GILD Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Gilead Sciences Inc. Stock Analysis GILD
United States Health Care Large Cap Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 17,600 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. The company is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The firm operates in more than 35 countries.
Read More GILD Chart
Gilead Sciences Inc vs S&P 500 Comparative Returns
Analysis of GILD stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Gilead Sciences... (GIL...) 6.27%
- S&P 500 -4.27%
Gilead Sciences Inc Outperformed S&P 500 by 10.54%
1Y Performance
- Gilead Sciences... (GIL...) 51.2%
- S&P 500 8.86%
Gilead Sciences Inc Outperformed S&P 500 by 42.34%
3Y Performance
- Gilead Sciences... (GIL...) 59.14%
- S&P 500 37.21%
Gilead Sciences Inc Outperformed S&P 500 by 21.93%
5Y Performance
- Gilead Sciences... (GIL...) 26.67%
- S&P 500 92.3%
Gilead Sciences Inc Underperformed S&P 500 by 65.63%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$98.07Volume
12.99MP/E Ratio (TTM)
270.9352 Week Range
Market Cap
132.93BAvg. Volume
9.44MDividend Yield
4.53%Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 19.69 | 21.77 | 21.88 | 21.76 | - |
EBIT per Share (TTM) | 3.25 | 7.91 | 8.04 | 7.91 | - |
Earnings per Share (EPS) (TTM) | 0.1 | 4.96 | 3.66 | 4.54 | - |
Dividend per Share (TTM) | 2.75 | 2.87 | 2.97 | 3.06 | - |
EPS Forward | - | - | 3.64 | 4.5 | 0.38 |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
Dodge & Cox
% Portfolio:
1.77 Recent Activity:-0.30%
John Rogers
% Portfolio:
0.39 Recent Activity:68.66%
Joel Greenblatt
% Portfolio:
0.22 Recent Activity:0.34%
Richard Pzena
% Portfolio:
< 0.01 Recent Activity:22.83%
Community-Curated Collections ( With GILD )
View AllCommunity-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.
Nasdaq-100 Index
By Dilnoza Mirsaidova
61 Followers
Biotech & Drugs
By Bunyod Rayim
44 Followers
My Watchlist
By Mustafa SARICA
15 Followers
A
By Mustafa SARICA
12 Followers
Halal stocks in Nasdaq 100 index
By Investment Alchemist
9 Followers
S&P 500 TOP 100 Halal Stock Selection (Regular updates)
By Tharawen Fridhi
6 Followers
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
